Literature DB >> 9135262

Intracranial hypertension in Africans with cerebral malaria.

C R Newton1, J Crawley, A Sowumni, C Waruiru, I Mwangi, M English, S Murphy, P A Winstanley, K Marsh, F J Kirkham.   

Abstract

The causes of death and neurological sequelae in African children with cerebral malaria are obscure. Intracranial pressure (ICP) was monitored and cerebral perfusion pressure (CPP) calculated in 23 Kenyan children with cerebral malaria. Four children had severe intracranial hypertension (ICP > 40 mm Hg, CPP < 40 mm Hg): two died, one with an ICP of 158 mm Hg and signs of transtentorial herniation, the other one with an ICP of 42 mm Hg and cardiorespiratory arrest. The other two survived with severe neurological sequelae. Nine had intermediate intracranial hypertension (ICP > 20 mm Hg, CPP < 50 mm Hg) and 10 had mild intracranial hypertension (maximum ICP 10-20 mm Hg); all survived without severe sequelae. Mannitol controlled the ICP in children with intermediate intracranial hypertension, but it did not prevent the development of intractable intracranial hypertension in children with severe intracranial hypertension. Intracranial hypertension is a feature of Kenyan children with cerebral malaria and severe intracranial hypertension is associated with a poor outcome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135262      PMCID: PMC1717090          DOI: 10.1136/adc.76.3.219

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  28 in total

1.  Perturbations of cerebral hemodynamics in Kenyans with cerebral malaria.

Authors:  C R Newton; K Marsh; N Peshu; F J Kirkham
Journal:  Pediatr Neurol       Date:  1996-07       Impact factor: 3.372

2.  The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localised within the brain.

Authors:  N A Lassen
Journal:  Lancet       Date:  1966-11-19       Impact factor: 79.321

3.  Intracranial pressure: monitoring and normalization therapy in children.

Authors:  J J Mickell; D H Reigel; D R Cook; R E Binda; P Safar
Journal:  Pediatrics       Date:  1977-04       Impact factor: 7.124

4.  Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa.

Authors:  B M Greenwood; A K Bradley; A M Greenwood; P Byass; K Jammeh; K Marsh; S Tulloch; F S Oldfield; R Hayes
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

5.  Intracranial pressure in African children with cerebral malaria.

Authors:  C R Newton; F J Kirkham; P A Winstanley; G Pasvol; N Peshu; D A Warrell; K Marsh
Journal:  Lancet       Date:  1991-03-09       Impact factor: 79.321

6.  Non-traumatic coma in childhood: clinical variables in prediction of outcome.

Authors:  S S Seshia; B Johnston; G Kasian
Journal:  Dev Med Child Neurol       Date:  1983-08       Impact factor: 5.449

7.  Cerebral perfusion pressure and auditory brain-stem responses in childhood CNS diseases.

Authors:  K J Goitein; P Fainmesser; H Sohmer
Journal:  Am J Dis Child       Date:  1983-08

8.  Magnetic resonance imaging of the brain in patients with cerebral malaria.

Authors:  S Looareesuwan; P Wilairatana; S Krishna; B Kendall; S Vannaphan; C Viravan; N J White
Journal:  Clin Infect Dis       Date:  1995-08       Impact factor: 9.079

9.  Intracranial pressure in childhood central nervous system infections.

Authors:  P Rebaud; J C Berthier; E Hartemann; D Floret
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

10.  TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

Authors:  D Kwiatkowski; A V Hill; I Sambou; P Twumasi; J Castracane; K R Manogue; A Cerami; D R Brewster; B M Greenwood
Journal:  Lancet       Date:  1990-11-17       Impact factor: 79.321

View more
  53 in total

Review 1.  Non-traumatic coma in children.

Authors:  F J Kirkham
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

Review 2.  Neurologic aspects of infections in international travelers.

Authors:  May H Han; Joseph R Zunt
Journal:  Neurologist       Date:  2005-01       Impact factor: 1.398

Review 3.  Management of severe malaria in children: proposed guidelines for the United Kingdom.

Authors:  Kathryn Maitland; Simon Nadel; Andrew J Pollard; Thomas N Williams; Charles R J C Newton; Michael Levin
Journal:  BMJ       Date:  2005-08-06

Review 4.  Malaria: an update on treatment of adults in non-endemic countries.

Authors:  Christopher J M Whitty; David Lalloo; Andrew Ustianowski
Journal:  BMJ       Date:  2006-07-29

Review 5.  Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis.

Authors:  Melanie Walker; James G Kublin; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2005-11-23       Impact factor: 9.079

Review 6.  Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria.

Authors:  Christy An Okoromah; Bosede B Afolabi; Emma Cb Wall
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

Review 7.  Diagnosis and management of the neurological complications of falciparum malaria.

Authors:  Saroj K Mishra; Charles R J C Newton
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

Review 8.  Cerebral malaria.

Authors:  C R Newton; T T Hien; N White
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

9.  Ectophosphorylation of CD36 regulates cytoadherence of Plasmodium falciparum to microvascular endothelium under flow conditions.

Authors:  May Ho; Holly L Hoang; Kristine M Lee; Naili Liu; Tara MacRae; Laura Montes; Christine L Flatt; Bryan G Yipp; Bradley J Berger; Sorrnchai Looareesuwan; Stephen M Robbins
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 10.  The role for osmotic agents in children with acute encephalopathies: a systematic review.

Authors:  Samson Gwer; Hellen Gatakaa; Leah Mwai; Richard Idro; Charles R Newton
Journal:  BMC Pediatr       Date:  2010-04-17       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.